1.79
4.79%
-0.09
PAVmed Inc 주식(PAVM)의 최신 뉴스
PAVmed (NASDAQ:PAVM) Raised to Strong-Buy at Lake Street Capital - Defense World
Defense World
PAVmed Inc. (NASDAQ:PAVM) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
PAVmed Inc Provides Informal Financial Performance Update - TipRanks.com - TipRanks
TipRanks
Earnings call: PAVmed discusses Q1 2024 results, subsidiary progress - Investing.com
Investing.com
PAVmed earnings beat by $0.51, revenue fell short of estimates - Investing.com South Africa
Investing.com South Africa
PAVmed Provides Business Update - citybiz
citybiz
PAVmed Provides Business Update and First Quarter 2024 Financial Results - PR Newswire
PR Newswire
Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results - Nasdaq
Nasdaq
Legacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA Recall - BioSpace
BioSpace
Legacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA Recall – Company ... - Financial Times
Financial Times
Here's Why PAVmed Inc. (PAVM) Is a Great 'Buy the Bottom' Stock Now - Yahoo News UK
Yahoo News UK
Lucid Diagnostics Appoints Dennis Matheis to Board of Directors - citybiz
citybiz
Lucid Diagnostics Closes Series B / B-1 Preferred Stock Offering and Appoints Healthcare Industry Veteran Dennis ... - PR Newswire
PR Newswire
PAVmed to Hold a Business Update Conference Call and Webcast on May 14, 2024 - Investing.com India
Investing.com India
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 13, 2024 - BioSpace
BioSpace
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 13, 2024 - Morningstar
Morningstar
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 13, 2024 - The Malaysian Reserve
The Malaysian Reserve
PAVmed Subsidiary, Veris Health, Signs Memorandum of Understanding with The Ohio State University ... - PR Newswire
PR Newswire
Lucid Diagnostics Partners with the Esophageal Cancer Action Network (ECAN) to Highlight Esophageal Cancer ... - BioSpace
BioSpace
Lucid Diagnostics Partners with the Esophageal Cancer Action Network (ECAN) to Highlight Esophageal Cancer ... - InvestorsObserver
InvestorsObserver
Why PAVmed Inc. (PAVM) Dipped More Than Broader Market Today
Zacks Investment Research
Lucid Diagnostics to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference - PR Newswire
PR Newswire
Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket
Benzinga
PAVmed Inc. (NASDAQ:PAVM) Q4 2023 Earnings Call Transcript - Yahoo Finance
Yahoo Finance
Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga
New Strong Buy Stocks for March 27th
Zacks Investment Research
PAVmed Full Year 2023 Earnings: EPS Beats Expectations - Yahoo Finance
Yahoo Finance
PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results - PR Newswire
PR Newswire
Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2023 Financial Results - PR Newswire
PR Newswire
Lucid Diagnostics Announces Positive Data from the First Prospective Clinical Validation Study of EsoGuard ... - PR Newswire
PR Newswire
Lucid Diagnostics Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference - PR Newswire
PR Newswire
PAVmed Inc. Distributes Lucid Stock and Adjusts Warrant Terms - TipRanks.com - TipRanks
TipRanks
Lucid Diagnostics Provides Update Regarding World Trade Center Health Program - PR Newswire
PR Newswire
Lucid Diagnostics Chairman & CEO, Dr. Lishan Aklog, Highlights EsoCheck® Esophageal Cell Collection Device ... - PR Newswire
PR Newswire
PAVmed Inc. Grants Shareholders Lucid Diagnostics Dividend - TipRanks.com - TipRanks
TipRanks
Lucid Diagnostics Executes Contract to Provide EsoGuard® Esophageal Precancer Testing as a Covered Benefit for 9 ... - PR Newswire
PR Newswire
Lucid Diagnostics Issues Stock for PAVmed Compensation - TipRanks.com - TipRanks
TipRanks
PAVmed Inc Acquires Lucid Shares to Settle Debt - TipRanks.com - TipRanks
TipRanks
Are Investors Undervaluing PAVmed Inc. (NASDAQ:PAVM) By 28%? - Simply Wall St
Simply Wall St
Why Richardson Electronics Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket
Benzinga
The 3 Most Undervalued Penny Stocks to Buy in December - InvestorPlace
InvestorPlace
Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Results from Three Clinical Utility Studies - PR Newswire
PR Newswire
PAVmed Provides Additional Details for Upcoming Stock Dividend to Shareholders - PR Newswire
PR Newswire
Shareholders in PAVmed (NASDAQ:PAVM) have lost 88%, as stock drops 30% this past week - Simply Wall St
Simply Wall St
Penny Stock Jackpots: 3 High-Stakes Picks With 10-Bagger Potential - InvestorPlace
InvestorPlace
PAVmed Announces Dividend of Lucid Diagnostics Common Stock and Reverse Stock Split - PR Newswire
PR Newswire
Lucid Diagnostics Strengthens and Expands Market Access and Direct Contracting Efforts - PR Newswire
PR Newswire
PAVmed Provides Business Update and Third Quarter Financial Results - PR Newswire
PR Newswire
Lucid Diagnostics introduces new EsoGuard 2.0 DNA test - Medical Device Network
Medical Device Network
Lucid Diagnostics Launches Next-Generation EsoGuard® Esophageal DNA Test and Announces Upcoming Investor Day - PR Newswire
PR Newswire
자본화:
|
볼륨(24시간):